The investigators long term objectives are to elucidate the role of Smads (Sma/MAD), two of which have been demonstrated as tumor suppressor genes, in the mediation of transforming growth factor beta (TGF-b) growth inhibitory signal and evaluate the potential involvement of Smads in the process of tumorigenesis in an animal model system. As a multi-functional growth hormone, TGF-b regulates many different aspects of cellular functions, such as proliferation, differentiation, extracellular matrix deposition. However, the signal transduction pathways through which the various biological effects of TGF-b are mediated remain largely unknown. Recently, it has been demonstrated, by the investigator s laboratory and others, that Smads, discovered originally in the TGF-b-like DPP pathway in Drosophila, function as intermediators to transmit the TGF-b signal from the cytoplasm to the nucleus. Once in the nucleus, Smads participate in transcriptional activation of specific genes through a still poorly defined mechanism. In this context, they propose four specific aims to achieve the stated research goals. Their preliminary results demonstrated that Smad3/4 complex is induced by TGF-b to bind to promoter sequences. However, the mechanism by which Smad3/4 activates transcription through AP1 sites is still unclear. Based on those findings, Aim 1 will determine how the endogenous PAI-1 gene is activated by the Smads and Aim 2 will focus on the functional relationship between the Smads and AP1 complexes in the process of TGF-b mediated transcription activation.
Aim 3 will identify and isolate novel downstream target genes for Smad2 and Smad3 as mediators of TGF-b growth inhibitory signal.
Aim 4 will generate the expression profiles of Smad2 and Smad3 and create Smad3 null mice for analysis of the physiological roles of Smad3 during mouse development and its potential involvement in carcinogenesis. The accomplishment of these four aims will represent a significant step in the elucidation of a specific TGF-b signaling pathway downstream of the receptor complex. Since TGF-b is involved in the control of many cellular functions, a better understanding of its signaling pathways will not only provide insight into molecular events that lead to carcinogenesis in humans, but also help the development of new strategies for the treatment of human cancers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA075368-05
Application #
6513118
Study Section
Pathology B Study Section (PTHB)
Program Officer
Freeman, Colette S
Project Start
1998-07-01
Project End
2004-04-30
Budget Start
2002-05-01
Budget End
2004-04-30
Support Year
5
Fiscal Year
2002
Total Cost
$299,239
Indirect Cost
Name
Duke University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Waddell, David S; Liberati, Nicole T; Guo, Xing et al. (2004) Casein kinase Iepsilon plays a functional role in the transforming growth factor-beta signaling pathway. J Biol Chem 279:29236-46
Frederick, Joshua P; Liberati, Nicole T; Waddell, David S et al. (2004) Transforming growth factor beta-mediated transcriptional repression of c-myc is dependent on direct binding of Smad3 to a novel repressive Smad binding element. Mol Cell Biol 24:2546-59
Chen, Wei; Kirkbride, Kellye C; How, Tam et al. (2003) Beta-arrestin 2 mediates endocytosis of type III TGF-beta receptor and down-regulation of its signaling. Science 301:1394-7
Zhao, Jingsong; Shi, Wei; Wang, Yan-Ling et al. (2002) Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol 282:L585-93
Liberati, N T; Moniwa, M; Borton, A J et al. (2001) An essential role for Mad homology domain 1 in the association of Smad3 with histone deacetylase activity*. J Biol Chem 276:22595-603
Shen, X; Li, J; Hu, P P et al. (2001) The activity of guanine exchange factor NET1 is essential for transforming growth factor-beta-mediated stress fiber formation. J Biol Chem 276:15362-8
Rich, J; Borton, A; Wang, X (2001) Transforming growth factor-beta signaling in cancer. Microsc Res Tech 52:363-73
Borton, A J; Frederick, J P; Datto, M B et al. (2001) The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis. J Bone Miner Res 16:1754-64
Rich, J N; Zhang, M; Datto, M B et al. (1999) Transforming growth factor-beta-mediated p15(INK4B) induction and growth inhibition in astrocytes is SMAD3-dependent and a pathway prominently altered in human glioma cell lines. J Biol Chem 274:35053-8
Liberati, N T; Datto, M B; Frederick, J P et al. (1999) Smads bind directly to the Jun family of AP-1 transcription factors. Proc Natl Acad Sci U S A 96:4844-9

Showing the most recent 10 out of 11 publications